Advanced Science · 2020 · 16 citations · 53 references
Life SciencesBiomedical SciencesBiotechnologyBiocompatibilityInflammationProteomicsCell-nanoparticle InteractionsNanomaterial CharacterizationNanomedicineNanoparticle CharacterizationNanotoxicologyProtein Corona FormationBiocompatible NanomaterialsBiocompatible NanoparticlesNanomaterial BiocompatibilityNanomaterial ImmunogenicityNanoparticle BiocompatibilityNanoparticle ImmunogenicityPorous SiliconProtein Corona
Abstract The analysis of nanoparticles’ biocompatibility and immunogenicity is mostly performed under a healthy condition. However, more clinically relevant evaluation conducted under pathological condition is less known. Here, the immunogenicity and bio–nano interactions of porous silicon nanoparticles (PSi NPs) are evaluated in an acute liver inflammation mice model. Interestingly, a new mechanism in which PSi NPs can remit the hepatocellular damage and inflammation activation in a surface dependent manner through protein corona formation, which perturbs the inflammation by capturing the pro‐inflammatory signaling proteins that are inordinately excreted or exposed under pathological condition, is found. This signal sequestration further attenuates the nuclear factor κ B pathway activation and cytokines production from macrophages. Hence, the study proposes a potential mechanism for elucidating the altered immunogenicity of nanomaterials under pathological conditions, which might further offer insights to establish harmonized standards for assessing the biosafety of biomaterials in a disease‐specific or personalized manner.
53
Martin Lundqvist, Johannes Stigler, Giuliano Elia et al. · Proceedings of the National Academy of Sciences · 2008 · 3K citations · Full text
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Stefan Tenzer, Dominic Docter, Jörg Kuharev et al. · Nature Nanotechnology · 2013 · 2.2K citations